Myocardial Cell Preservation from Potential Cardiotoxic Drugs: The Role of Nanotechnologies
Cardiotoxic therapies, whether chemotherapeutic or antibiotic, represent a burden for patients who may need to interrupt life-saving treatment because of serious complications. Cardiotoxicity is a broad term, spanning from forms of heart failure induction, particularly left ventricular systolic dysf...
Main Authors: | Adelaide Iervolino, Luigi Spadafora, Cristiano Spadaccio, Valentina Iervolino, Giuseppe Biondi Zoccai, Felicita Andreotti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/1/87 |
Similar Items
-
The broad spectrum of cardiotoxicities from immunotherapies
by: Martina Iengo, et al.
Published: (2023-09-01) -
Development of a Cardio-Oncology Service in Lithuania: Prediction, Prevention, Monitoring and Treatment of Cancer Treatment-Induced Cardiotoxicity
by: Eglė Čiburienė, et al.
Published: (2022-04-01) -
The Potential Cardiotoxicity of Immune Checkpoint Inhibitors
by: Inbar Nardi Agmon, et al.
Published: (2022-02-01) -
Exercise Cardio-Oncology: Exercise as a Potential Therapeutic Modality in the Management of Anthracycline-Induced Cardiotoxicity
by: Dong-Woo Kang, et al.
Published: (2022-01-01) -
ECG Scoring for the Evaluation of Therapy-Naïve Cancer Patients to Predict Cardiotoxicity
by: Julia Pohl, et al.
Published: (2021-03-01)